| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $850.8M | — | +14.1% |
| R&D Expense | $49.6M | — | +4.2% |
| SG&A Expense | $69.0M | — | +20.8% |
| Operating Income | $456.9M | — | +21.2% |
| Pre-tax Income | $389.2M | — | +17.6% |
| Income Tax | -$16.8M | — | -139.6% |
| Net Income | $406.0M | — | +40.7% |
| EPS (Basic) | $5.54 | — | +48.9% |
| EPS (Diluted) | $5.53 | — | +49.1% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $385.3M | -25.2% | +6.8% |
| Current Assets | $1.39B | -15.2% | +12.8% |
| Total Assets | $5.55B | -2.8% | +3.8% |
| Current Liabilities | $1.61B | -11.8% | +10.0% |
| Long-term Debt | $6.40B | +3.3% | +40.8% |
| Total Liabilities | $8.32B |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $306.8M | — | +1.7% |
| Capital Expenditures | $2.8M | — | -75.7% |
| Investing Cash Flow | -$70.5M | — | -114.3% |
| Financing Cash Flow | -$364.5M | — | -13.3% |
| Free Cash Flow | $304.0M | — | +4.7% |
| +32.0% |
| Stockholders' Equity | -$2.77B | -4.5% | -189.4% |